Peter D. Kies
2016
In 2016, Peter D. Kies earned a total compensation of $1.4M as Chief Financial Officer at Inovio Pharmaceuticals, a 35% increase compared to previous year.
Compensation breakdown
| Bonus | $144,514 |
|---|---|
| Option Awards | $290,868 |
| Salary | $385,573 |
| Stock Awards | $526,500 |
| Other | $8,268 |
| Total | $1,355,723 |
Kies received $526.5K in stock awards, accounting for 39% of the total pay in 2016.
Kies also received $144.5K in bonus, $290.9K in option awards, $385.6K in salary and $8.3K in other compensation.
Rankings
In 2016, Peter D. Kies' compensation ranked 6,755th out of 14,075 executives tracked by ExecPay. In other words, Kies earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,755 out of 14,075 | 52nd |
Division Manufacturing | 2,520 out of 5,486 | 54th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 340 out of 819 | 59th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 185 out of 502 | 63rd |
Industry Surgical and Medical Instruments and Apparatus | 100 out of 305 | 67th |
Source: SEC filing on March 29, 2017.
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2016.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019